Analysis of information sources in references of the Wikipedia article "קנדידיאזיס" in Hebrew language version.
{{cite journal}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה)Candida species and other microorganisms are involved in this complicated fungal infection, but Candida albicans continues to be the most prevalent. In the past two decades, it has been observed an abnormal overgrowth in the gastrointestinal, urinary and respiratory tracts, not only in immunocompromised patients but also related to nosocomial infections and even in healthy individuals. There is a wide variety of causal factors that contribute to yeast infection which means that candidiasis is a good example of a multifactorial syndrome.
{{cite journal}}: (עזרה)Small intestinal fungal overgrowth (SIFO) is characterized by the presence of excessive number of fungal organisms in the small intestine associated with gastrointestinal (GI) symptoms. Candidiasis is known to cause GI symptoms particularly in immunocompromised patients or those receiving steroids or antibiotics. However, only recently, there is emerging literature that an overgrowth of fungus in the small intestine of non-immunocompromised subjects may cause unexplained GI symptoms. Two recent studies showed that 26 % (24/94) and 25.3 % (38/150) of a series of patients with unexplained GI symptoms had SIFO. The most common symptoms observed in these patients were belching, bloating, indigestion, nausea, diarrhea, and gas. The underlying mechanism(s) that predisposes to SIFO is unclear but small intestinal dysmotility and use of proton pump inhibitors has been implicated. However, further studies are needed; both to confirm these observations and to examine the clinical relevance of fungal overgrowth, both in healthy subjects and in patients with otherwise unexplained GI symptoms. ... For routine SIFO in an immunocompetent host, a 2–3 week oral course of fluconazole 100–200 mg will suffice.
{{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה)Thus, the available evidence for the use of probiotics for prevention of recurrent VVC is limited
{{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite web}}: (עזרה){{cite web}}: (עזרה)Candida species and other microorganisms are involved in this complicated fungal infection, but Candida albicans continues to be the most prevalent. In the past two decades, it has been observed an abnormal overgrowth in the gastrointestinal, urinary and respiratory tracts, not only in immunocompromised patients but also related to nosocomial infections and even in healthy individuals. There is a wide variety of causal factors that contribute to yeast infection which means that candidiasis is a good example of a multifactorial syndrome.
{{cite journal}}: (עזרה)Small intestinal fungal overgrowth (SIFO) is characterized by the presence of excessive number of fungal organisms in the small intestine associated with gastrointestinal (GI) symptoms. Candidiasis is known to cause GI symptoms particularly in immunocompromised patients or those receiving steroids or antibiotics. However, only recently, there is emerging literature that an overgrowth of fungus in the small intestine of non-immunocompromised subjects may cause unexplained GI symptoms. Two recent studies showed that 26 % (24/94) and 25.3 % (38/150) of a series of patients with unexplained GI symptoms had SIFO. The most common symptoms observed in these patients were belching, bloating, indigestion, nausea, diarrhea, and gas. The underlying mechanism(s) that predisposes to SIFO is unclear but small intestinal dysmotility and use of proton pump inhibitors has been implicated. However, further studies are needed; both to confirm these observations and to examine the clinical relevance of fungal overgrowth, both in healthy subjects and in patients with otherwise unexplained GI symptoms. ... For routine SIFO in an immunocompetent host, a 2–3 week oral course of fluconazole 100–200 mg will suffice.
{{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה)Thus, the available evidence for the use of probiotics for prevention of recurrent VVC is limited
{{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite journal}}: (עזרה){{cite web}}: (עזרה)